A large number of experimental studies have shown that cancer cells exhibit deregulated transcriptional levels of several genes involved in cholesterol regulation and metabolism such as low-density lipoprotein receptor (LDLR), HMG-CoA reductase (HMGCR) and sterol regulatory element-binding protein (SREBPS) [16,17]. The gene discussed is LDLR; the disease is cancer.